Highlights Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-21			5-day change	1st Jan Change
30.87 ^CNY	-0.16%		-5.97%	+8.58%

04:18am	Pharmaron Beijing Completes HK$1.32 Billion Share Offering	MT
Jan. 14	Pharmaron Beijing to place 58.4 million new H shares at RMB1.00 per share	RE

Highlights

04:18am	Pharmaron Beijing Completes HK$1.32 Billion Share Offering	MT
Jan. 14	Pharmaron Beijing Seeking HK$1.33 Billion via Stock Offering	MT
Jan. 13	Pharmaron Beijing Expects Lower 2025 Profit	MT
Jan. 13	Pharmaron Beijing Co., Ltd. Provides Earnings Guidance for the Financial Year Ended December 31, 2025	CI
Jan. 13	Pharmaron Beijing sees 2025 net profit down 6-10%	RE
Dec. 18	Pharmaron Beijing Co., Ltd. Announces Election of Mr. Li Shing Chung Gilbert as Employee Representative Director Effective December 18, 2025	CI
25-10-28	Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-10-28	Pharmaron Beijing Q3 net profit up 42.5% Y/Y	RE
25-10-27	Pharmaron Beijing Co., Ltd. agreed to acquire 3.08% stake in Wuxi Biortus Biosciences Co. Ltd. from Jiangyin Baiao Management Consulting Enterprise (Limited Partnership), Jiangyin Baisheng Management Consulting Center (Limited Partnership), Jiangyin Baichuang Management Consulting Center (Limited Partnership) and Jiangyin Baiying Management Consulting Center (Limited Partnership), Wu Jiaquan for CNY 27.2 million.	CI
25-09-15	Pharmaron's Shaoxing Unit Passes US FDA On-Site Inspection	MT
25-08-22	Pharmaron Beijing H1 Profit Falls 37%, Revenue Rises 15%	MT
25-08-21	Pharmaron Beijing's H1 Profit Falls 37%	MT
25-08-21	Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-08-21	Pharmaron Beijing reports HY aggregate revenue of RMB6,441.0 million	RE
25-07-16	Hong Kong Stocks Fall as Trade Uncertainty Looms, HKMA Steps In to Defend Currency Peg	MT
25-07-15	Pharmaron Beijing Expects Up to 39% Drop in H1 Profit; Shares Decline 4%	MT
25-07-15	Pharmaron Beijing Co., Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2025	CI
25-07-15	Pharmaron Beijing sees H1 net profit down 36-39% Y/Y	RE
25-06-20	Pharmaron Beijing Co., Ltd. Approves Final Ordinary Dividend for Year Ended December 31, 2024, Payment Date Is 06 August 2025	CI
25-06-04	Pharmaron Beijing Co., Ltd.'s Equity Buyback announced on December 16, 2024, has expired.	CI
25-06-02	Pharmaron Beijing's UK Unit to Invest $30 Million in Biotech Fund	MT
25-04-28	Pharmaron Beijing's Q1 Profit Balloons 33%	MT
25-04-27	Pharmaron Beijing Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-23	CN Bio Announces Establishment of Strategic Partnership with Pharmaron	CI
25-03-27	Pharmaron Beijing's 2024 Profit Jumps 12%; Shares Rise 3%	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

Biotechnology & Medical Research

Highlights

Filters